$CSTM

CONSTELLIUM SE

1
0
0

No SEC Form 4 filings for $CSTM in the last 30 days.

Med

Constellium (NYSE:CSTM) Shares Pass Above 200 Day Moving Average – Here’s Why

Constellium SE (NYSE:CSTM) shares moved above their 200-day moving average on Monday, trading up to $33.54 and last at $33.26 versus a 200-day average near $23.72. The stock also saw analyst changes: Zacks upgraded to strong-buy; Deutsche Bank reiterated buy with a $40 target; JPMorgan raised its $34 target. The company reported April 29 EPS of $1.42 and revenue of $2.46B, and approved a $300M buyback.

Constellium (NYSE:CSTM) Downgraded to "Neutral" Rating by JPMorgan Chase & Co.

JPMorgan Chase & Co. downgraded Constellium (NYSE:CSTM) from an "overweight" to a "neutral" rating, setting a $34 price target. This downgrade comes despite Constellium beating Q1 earnings estimates, raising full-year guidance, and authorizing a $300 million share repurchase plan. Key concerns include significant insider selling, relatively high leverage, and mixed analyst sentiment, which may increase the company's sensitivity to commodity prices and execution.

Constellium and PyroGenesis partner to advance plasma burner technology in aluminium melting process

Constellium SE and PyroGenesis Canada Inc. have partnered to test plasma torch technology for decarbonizing aluminium melting processes. After successful laboratory trials, the companies will implement a demonstrator plasma-heated furnace system in a Constellium casthouse. This technology has the potential to significantly reduce direct emissions in aluminium production, aligning with Constellium's decarbonization roadmap.

News on $CSTM